MAPK8 and glioblastoma: Recently it was demonstrated in vitro that JNK is required for the maintenance of the self-renewal and tumor-initiating capacity of human glioblastoma and pancreatic cancer stem cells (CSCs) or cancer stem-like cells (CSLCs) [37].